Coolest MTB

Sufferers that have gynecologic cancer have fresh new hope in a innovative technology currently offered at the Seidman Cancer Center at University Hospitals Case Medical Center. A team of cancer specialists, led by Robert DeBernardo, MD, is among the first in the nation to launch a dedicated program using Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat ovarian, endometrial and select other cancers.

Carried out as soon as possible following surgical treatment, HIPEC makes available heated chemotherapy through a ‘hot bath’ into the abdominal cavity, where it can penetrate diseased tissue directly. Once the surgeon removes the maximum visible cancer as workable, a heated, a sterilized chemotherapy solution is distributed throughout the midsection by way of a technically advanced perfusion procedure to eradicate the residual cancer cells.

“This is a new and potentially revolutionary way of treating women with gynecologic cancers, which tend to be quite responsive to chemotherapy,” says Dr. DeBernardo, gynecologic oncologist at UH Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine. “Our preliminary data and experience has been overwhelmingly positive and the therapy has been well-tolerated and effective. HIPEC promises to extend lives in a meaningful way.”

HIPEC has been used for years for public health care in patients with colon, pseudomyxomas, malignant mesothelioma and appendiceal cancer, varieties of cancer of which usually are not receptive to chemotherapy, but it is now seen as a promising new therapy for gynecologic malignancy.